| Hand Therapy Of Michigan | |
|
8175 Creekside Dr Ste 100, Portage, MI 49024-5370 | |
| (269) 321-3011 | |
| (269) 321-3014 |
| Full Name | Hand Therapy Of Michigan |
|---|---|
| Type | Facility |
| Speciality | Occupational Therapist |
| Location | 8175 Creekside Dr Ste 100, Portage, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073037313 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Hand Therapy Of Michigan 3600 Capital Ave Sw, Battle Creek, MI 49015-9393 Ph: (269) 979-0874 | Hand Therapy Of Michigan 8175 Creekside Dr Ste 100, Portage, MI 49024-5370 Ph: (269) 321-3011 |
News Archive
The Governor's Office of Health Care Reform has received more than $17 million in federal Recovery Act funds to help develop a health information "superhighway" to connect health care practitioners, patients, facilities and pharmacies through a secure network giving them the ability to have a complete record of a patient's medical history.
During the first 9 months of the COVID-19 pandemic, researchers did not find a significant difference in the number of new cancer diagnoses in Canadian children compared with before the pandemic, according to a study published in CMAJ.
SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, today announced that ITOCHU CHEMICAL FRONTIER Corporation (ICF, Tokyo Japan), a member of ITOCHU Corporation, one of the three leading sogo shosha (general trading companies) in Japan, has made a strategic investment in SCILEX.
Results from a US study suggest there is dysfunction in the neural networks responsible for emotion regulation among patients with bipolar I disorder, even during periods of euthymia.
A clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa. The drug, moxidectin, is being investigated for its potential to kill or sterilize the adult worms of Onchocerca volvulus, which cause onchocerciasis.
› Verified 5 days ago
Denise L Hoffman, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5833 Oakland Dr, Suite 2, Portage, MI 49024 Phone: 269-330-2113 | |
Mosab Aziz, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1806 Lansing Ave, Portage, MI 49002 Phone: 269-349-2641 | |
Renu Sharma, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5817 S Westnedge Ave, Portage, MI 49002 Phone: 269-385-3000 Fax: 000-000-0000 | |
Barbara Mauragis, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2615 Hill An Brook Dr, Portage, MI 49024 Phone: 269-344-3066 | |
Mrs. Jennifer Lynn Sandborn, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7855 Currier Dr, Portage, MI 49002 Phone: 269-323-7748 Fax: 269-323-1908 | |
Pamela K. Kloosterman, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7920 Kirkland Ct, Portage, MI 49024 Phone: 269-381-7246 Fax: 269-345-5354 |